Note 12 - Financial Instruments - Summary of Effect of Designated Derivative Financial Instruments on Consolidated Financial Statements (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Cost of sales	$ 2,302	$ 2,230	$ 4,284	$ 4,405
Other Nonoperating Income (Expense)	33	87	107	95
Gain (loss) recognized in other comprehensive income	(24)	42	9	74
Net income of reportable segments	104	281	313	457
Reclassification out of Accumulated Other Comprehensive Income [Member]
Cost of sales	15	11	21	18
Other Nonoperating Income (Expense)	(1)	(1)	(1)	(2)
Net income of reportable segments	14	10	20	16
Foreign Exchange Contract [Member]
Cost of sales	$ (24)	$ 42	$ 9	$ 74